Phreesia (NYSE:PHR) Earns Outperform Rating from Analysts at BMO Capital Markets

Investment analysts at BMO Capital Markets assumed coverage on shares of Phreesia (NYSE:PHR) in a research note issued on Thursday, Marketbeat Ratings reports. The brokerage set an “outperform” rating and a $32.00 price target on the stock. BMO Capital Markets’ price target points to a potential upside of 40.67% from the stock’s previous close.

Several other research analysts also recently weighed in on PHR. Citigroup reissued an “outperform” rating on shares of Phreesia in a research report on Monday, September 8th. DA Davidson raised Phreesia to a “strong-buy” rating in a research note on Monday, September 8th. KeyCorp lowered their price objective on shares of Phreesia from $35.00 to $32.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 8th. JMP Securities boosted their price target on shares of Phreesia from $30.00 to $34.00 and gave the company a “market outperform” rating in a report on Monday, September 8th. Finally, Truist Financial increased their price objective on Phreesia from $35.00 to $36.00 and gave the stock a “buy” rating in a report on Friday, September 5th. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $33.71.

Phreesia Trading Down 1.7%

PHR traded down $0.40 on Thursday, reaching $22.75. 56,391 shares of the company’s stock were exchanged, compared to its average volume of 597,863. Phreesia has a twelve month low of $17.07 and a twelve month high of $32.76. The company’s 50 day moving average is $23.67 and its 200-day moving average is $25.86. The company has a debt-to-equity ratio of 0.02, a quick ratio of 2.12 and a current ratio of 2.12. The company has a market cap of $1.36 billion, a price-to-earnings ratio of -54.13 and a beta of 0.74.

Phreesia (NYSE:PHR) last announced its earnings results on Thursday, September 4th. The company reported $0.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.08. Phreesia had a negative return on equity of 8.75% and a negative net margin of 5.35%.The business had revenue of $117.26 million for the quarter, compared to analyst estimates of $116.39 million. During the same period in the previous year, the company earned ($0.03) earnings per share. The company’s revenue for the quarter was up 14.9% compared to the same quarter last year. Phreesia has set its FY 2026 guidance at EPS. Equities analysts predict that Phreesia will post -1.1 earnings per share for the current year.

Insiders Place Their Bets

In other news, SVP Amy Beth Vanduyn sold 1,762 shares of Phreesia stock in a transaction that occurred on Tuesday, September 16th. The stock was sold at an average price of $23.28, for a total transaction of $41,019.36. Following the sale, the senior vice president owned 112,479 shares of the company’s stock, valued at approximately $2,618,511.12. This trade represents a 1.54% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Balaji Gandhi sold 4,183 shares of the business’s stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $23.28, for a total transaction of $97,380.24. Following the completion of the sale, the chief financial officer directly owned 99,125 shares in the company, valued at $2,307,630. This trade represents a 4.05% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 92,244 shares of company stock valued at $2,680,720 in the last quarter. 5.50% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Legal & General Group Plc boosted its stake in Phreesia by 8.8% in the 3rd quarter. Legal & General Group Plc now owns 71,000 shares of the company’s stock worth $1,670,000 after purchasing an additional 5,719 shares during the period. Swiss National Bank grew its stake in shares of Phreesia by 7.8% during the 3rd quarter. Swiss National Bank now owns 115,300 shares of the company’s stock worth $2,712,000 after acquiring an additional 8,300 shares in the last quarter. Dynamic Technology Lab Private Ltd bought a new position in shares of Phreesia in the 3rd quarter valued at about $662,000. Vinva Investment Management Ltd acquired a new stake in shares of Phreesia in the third quarter valued at about $428,000. Finally, First Trust Advisors LP boosted its position in Phreesia by 3.8% during the third quarter. First Trust Advisors LP now owns 175,010 shares of the company’s stock valued at $4,116,000 after purchasing an additional 6,380 shares during the last quarter. Institutional investors own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.